Sublingual Immunotherapy Stops Onset and Worsening of Asthma

The French EfficAPSI study confirmed that sublingual liquid immunotherapy or "desensitization" reduces the risks for asthma onset and the worsening of asthma in patients with allergic rhinitis.

Related Keywords

France , Paris , France General , Germany , French , German , Pascal Demoly , Stallergenes Greer , Philippe Devillier , French Health Authority , Montpellier University Hospital , French National Health Data System , Jocelyne Just , Foch Hospital , Asthma , Sthmatic , Airborne Allergy , Otolaryngology , Nt Ears , Nose , Throat , Allergic Rhinitis , Rhinitis , Severe Asthma , Immunotherapy , Allergens , Allergy , Hospitals , Biologic Therapy , Practice Management , Financial Reimbursement , Inhaler , Inhaled Corticosteroids , Intranasal Corticosteroids , Nasal Corticosteroids , Clinical Research , Clinical Trials , Linical Studies , Corticosteroid , Meta Analysis , Respiratory Tra ,